5-Bromo-2-(3-(chloromethyl)phenyl)pyrimidine – (1100598-50-2)

Glemanserin, 107703-78-6, MDL 11, 939, alpha-Phenyl-1-(2-phenylethyl)-4-piperidinemethanol, Mdl 11939, Mdl-11, 939, MDL-11939, phenyl-[1-(2-phenylethyl)piperidin-4-yl]methanol, Glemanserina, Glemanserine, 132553-86-7, Glemanserin [USAN:INN], X96LS7MC5Z, 4-Piperidinemethanol, alpha-phenyl-1-(2-phenylethyl)-, GLEMANSERIN [INN], GLEMANSERIN [USAN], CHEMBL18972, DTXSID4042624, (+-)-1-Phenethyl-alpha-phenyl-4-piperidinemethanol, phenyl-(1-(2-phenylethyl)piperidin-4-yl)methanol, UNII-X96LS7MC5Z, glemanserinum, MDL11939, Glemanserin (USAN/INN), Glemanserin, MDL11939, GTPL186, SCHEMBL120012, DTXCID2022624, CHEBI:91790, AXNGJCOYCMDPQG-UHFFFAOYSA-N, HMS3266L14, HMS3411B04, HMS3675B04, 4-Piperidinemethanol, alpha-phenyl-1-(2-phenylethyl)-, (+-)-, HEA70378, BDBM50004327, MDL11, 939, PDSP1_001574, PDSP2_001558, AKOS024458672, MS-24232, DB-115176, HY-101250, CS-0021037, (1-Phenethyl-piperidin-4-yl)-phenyl-methanol, D04320, G78296, phenyl[1-(2-phenylethyl)piperidin-4-yl]methanol, 4-Piperidinemethanol, a-phenyl-1-(2-phenylethyl)-, L002081, SR-01000597432, Q5567525, SR-01000597432-1, BRD-A62057054-001-01-5, BRD-A62057054-001-03-1, alpha-phenyl-[1-(2-phenylethyl )]-4-piperidinemethanol, alpha-phenyl-[1-(2-phenylethyl)]-4-piperidinemethanol, (+/-)-1-PHENETHYL-.ALPHA.-PHENYL-4-PIPERIDINEMETHANOL, MDL 11, 939phenyl[1-(2-phenylethyl)piperidin-4-yl]methanol, 4-PIPERIDINEMETHANOL, .ALPHA.-PHENYL-1-(2-PHENYLETHYL)-, (+/-)-, a-Phenyl-1-(2-phenylethyl)-4-piperidinemethanol Glemanserin MDL 11939